Introduction Although brain iron dysregulation has been implicated in neurological and neuropsychiatric disorders, its potential as a therapeutic target remains unclear. Deferiprone (DFP), an oral...
<p><strong>Tác giả:</strong> Ruiying Cheng, Hwayoung Baek, Jonghan Kim</p>
<p>Introduction Although brain iron dysregulation has been implicated in neurological and neuropsychiatric disorders, its potential as a therapeutic target remains unclear. Deferiprone (DFP), an oral lipophilic iron chelator approved for systemic iron overload, has been explored for central nervous system (CNS) disorders, but its use has been limited by systemic toxicity and suboptimal brain distribution. In this study, we evaluated intranasal (IN) delivery of DFP as an alternative strategy to m...</p>
<p>📄 DOI: <a href="https://doi.org/https://doi.org/10.3389/fphar.2026.1971846" target="_blank" rel="noopener">https://doi.org/10.3389/fphar.2026.1971846</a></p>
<p>📖 <a href="https://doi.org/https://doi.org/10.3389/fphar.2026.1971846" target="_blank" rel="noopener">Xem bài báo đầy đủ</a></p>
Bài viết được biên soạn lại bởi LIFVietnam. Nguồn tham khảo: OpenAlex
